Healthcare's Bio/Pharma-Fueled Bull Continues; But

its advance has effectively stalled just above it's Deep Crab PRZ, and at a confluence of APF and structured resistance. Reflecting the ebb in momentum, XLV's rate-of-change is at its lowest since December 2012.